The Covid-19 outbreak has no major impact on Helpinghand-pharmacy activities. However, depending on the region, there may be slight shipping delays.
Anaridex (Anastrozole)
Anaridex (Anastrozole)

* For illustration purpose only

Anaridex (Anastrozole)

Not in stock

Category: Women's Health
Commercial Name: Anaridex 
Principal Ingredient: Anastrozole
Relieves: Treats the problem of women's Health
Available Dosage: 400 mg
Delivery information
No delivery to USA

* Prices in the list do not apply to Switzerland. Customers are advised to place an order, and our team will contact back with updated prices.

There are 21 users looking at this product right now

We`d be happy to contact you as soon as this item is available
Simply enter your email in the space below
Anaridex (Anastrozole) is an aromatase hormone antagonist. It reats the problem of women's Health. During the postmenopausal period, estradiol is produced by converting androstenedione to estrone in peripheral tissues under the action of the aromatase enzyme. Then estrone is converted to estradiol. The active substance of the drug blocks this process. This reduces the level of estradiol, which is necessary in the treatment of breast cancer. Does not have progestogenic and androgenic activity.
Indication for use
Anaridex (Anastrozole) can be taken by almost all women who have to treat common breast cancer in postmenopausal women (with positive hormone receptors).
Anaridex (Anastrozole) is not recommended to use if you have:
severe renal insufficiency;
medium and severe hepatic insufficiency (safety and efficacy not established);
concomitant tamoxifen therapy;
childhood (safety and efficacy not established);
hypersensitivity to anastrozole and other components of the drug.
The drug is not prescribed to premenopausal women.
Dose and usage
Anaridex (Anastrozole) is available in the form of 1mg white, round, flat tablet.
Anaridex (Anastrozole) is taken orally. The recommended dose for adults, including older women, is 1 tablet (1 mg) once a day.
For invasive breast cancers with positive hormone receptors at early stages in postmenopausal women, the recommended duration of adjuvant endocrine treatment is 5 years.
Side effects
Anorexia, hypercholesterolemia, hypercalcemia, nausea, diarrhea, hepatitis, elevation of thyroid levels,  headache, wrist tunnel syndrome, drowsiness, sensitivity disorders, hot flashes, anaphylaxis (manifested by shortness of breath, hypotension, cardiac arrest), dermatitis, exanthema, hair thinning, alopecia, polymorphic erythema, arthralgia, arthritis, joint impairment, osteoporosis, bone pain, myalgia, vaginal bleeding, vaginal dryness.


Medically reviewed by Dr. Josette Davignon

Last updated: 23.05.2023

  • Discreet packaging. Secure and confidential
  • 100% moneyback guarantee
  • No prescription required
Write your review